Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
about
Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Foreseen is a Danger AvoidedEffects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillationOral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysisCardioembolic Stroke.Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trialWarfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.Antithrombotics in heart failure.Venous thromboprophylaxis in acutely ill patients: nursing role.Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation.Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure RegistryAL cardiac amyloidosis and arterial thromboembolic events.Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke?Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy.Heart failure and cognitive impairment: challenges and opportunities.Warfarin and aspirin in patients with heart failure and sinus rhythm.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE RegistryAnticoagulation for heart failure: selecting the best therapy.Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.Thrombophilia, left ventricular dysfunction and intracardiac thrombi in children.Role of antithrombotic agents in heart failure.The older patient with heart failure: high risk for frailty and cognitive impairment.Anticoagulation in heart failure: current status and future direction.The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.Co-morbidities in heart failure.Anticoagulation in patients with left ventricular systolic dysfunction and sinus rhythm: when?Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation.The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis.Acute impact of conventional and eccentric cycling on platelet and vascular function in patients with chronic heart failure.Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban.Anticoagulation Therapy and NOACs in Heart Failure.Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.Neuropsychological functioning in heart transplant candidates.The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores.Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients.
P2860
Q26801341-F8317C82-D239-454F-8BBB-F500E6E38B15Q28175492-53627385-6D6B-4E29-9218-9F7BB59907DAQ28484769-BF13C97F-CF9F-48BB-BF67-95F230A3BB5AQ30238631-1756EA20-3ACF-48CA-A38E-69C7A6353396Q34565614-BD5CE5B8-994E-4745-AD9E-ED2888394874Q34648874-AF2055B9-5966-46E2-80A6-3115136D1617Q34965626-A26157DC-443E-4B4A-8AB5-C7F21E6D4CCFQ34990776-05DA263E-955B-461D-B2FD-15CCDA38AF46Q35539387-1EAAFFB6-1329-4B30-9822-0E09D4C07D56Q35554746-E1242B6C-95F8-4BED-98C7-689C722E14F5Q36011253-23B3DF41-BFE2-404B-8CA0-79811B1CC84BQ36146288-56D90408-7F85-4AD3-B10A-54BCC8B44E98Q36236408-F634FEEA-7BF3-4499-81CC-38AE296DA684Q36272786-469192BA-9269-441F-96D8-44342AFA02F7Q36282403-6D5912C4-D0B6-4C71-AD7A-2F5811A70C7AQ36953423-97F85A64-5C3B-4193-8C71-17DCB5836ED8Q37017400-45EF5832-B8D0-4FC2-AC2B-AA7482559FE3Q37045277-2CC22430-B3FB-4F1F-A3C6-53F4E588E8ACQ37495877-A0B8EE3F-CF88-42D4-BFD0-43E644434CE2Q37496051-E77F9465-7E9D-41B8-99DD-4962A13739AFQ37611041-F1D7065B-8408-450B-AFD5-0EC696D7D4C1Q37730557-6FA0E8F5-A108-4176-8769-EB4FA1C8862EQ37777419-3BB7E73D-7975-42B3-9767-F84DD0B84621Q37939117-13B9AB65-E668-43E1-97B8-58452609D76BQ37998952-00B586F0-2395-4BA8-AA95-11A94C34017FQ38034810-710A397A-949F-4488-838B-7DE6F3D953EDQ38044305-421A9756-9C64-4E61-8DA0-FAF1EF594139Q38064758-5A7D0A43-C59E-4FA3-982B-3D19F3467296Q38069787-EBA2B8B0-11C5-47D1-BA68-34A99879C9D9Q38101438-CBE38F20-643F-4B5F-8EF1-48EFC2F01B07Q38116784-BB7042D5-2E48-4982-BB5A-E76BF49A57A9Q38180390-CC9E9B76-4968-448E-B81C-CF4940C601E4Q38670790-E2D5D48A-43D1-4F5E-A963-517A4F18724AQ38902503-9ECC44DC-CBCE-4D52-A0F6-1FB991EAAAD0Q39135634-56B4E0EC-6095-4F50-900A-E7750944078EQ39148821-C07DCFD5-2B2F-457D-A095-FB558A8A91C1Q39248876-2382587C-05E0-4892-BB4B-F788FEC00036Q39524503-D4514871-D91C-4E13-9A03-B3D806FE92C2Q40690404-06D7F0AD-34C5-41D4-85EB-7C091F5AEFA7Q41472249-424BDA19-C798-44EE-8640-CDE9B96D85BC
P2860
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@ast
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@en
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@nl
type
label
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@ast
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@en
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@nl
prefLabel
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@ast
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@en
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@nl
P1476
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
@en
P304
P356
10.1016/S0735-1097(99)00033-9
P407
P577
1999-04-01T00:00:00Z